The prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in the breast: a meta-analysis
Open Access
- 11 December 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 17 (1), 1-9
- https://doi.org/10.1186/s12885-017-3855-7
Abstract
Invasive micropapillary carcinoma (IMPC) of the breast is a rare variant of invasive ductal carcinoma (IDC). The prognosis of IMPC compared with that of IDC remains controversial; we conducted a meta-analysis to evaluate the prognostic difference between IMPC and IDC. We searched the PubMed, Cochrane Library, and EMBASE databases for relevant studies comparing overall survival (OS), disease-specific survival (DSS), relapse-free survival (RFS), local-regional recurrence-free survival (LRRFS) or distant metastasis-free survival (DMFS) rates between IMPC and IDC. Fixed-effect and random-effect models were utilized based on the heterogeneity of the eligible studies. Heterogeneity was further evaluated by subgroup and sensitivity analyses. Fourteen studies with 1888 IMPC patients were included in the meta-analysis. The summarized odds ratio (OR) and 95% confidence interval (95% CI) was calculated to estimate the prognostic difference between IMPC and IDC. IMPC patients showed an unfavorable prognosis for RFS (OR; 2.04; 95% CI: 1.63–2.55) and LRRFS (OR: 2.82; 95% CI: 1.90–4.17) compared with IDC. However, no significant difference was observed in OS (OR: 0.93; 95% CI: 0.78–1.10), DSS (OR: 1.16; 95% CI: 0.95–1.40) and DMFS (OR: 0.95; 95% CI: 0.67–1.35) between IMPC and IDC. No obvious statistical heterogeneity was detected, except for DSS. Funnel plots and Egger’s tests did not reveal publication bias, except for RFS. This analysis showed that IMPC patients have a higher rate of loco-regional recurrence than IDC patients. However, OS, DSS and DMFS were not significantly different between IMPC and IDC. These results could help clinicians select therapeutic and follow-up strategies for IMPC patients.Keywords
Funding Information
- The National Natural Science Foundation of China (No. 81672613)
- Key Research and Development Program of Shandong Province (No.2015GSF118093, No.2016GGE2775)
- Shandong Science and Technology Development Plan (No.2016CYJS01A02)
- The National Natural Science Foundation of China (No. 81502285)
This publication has 40 references indexed in Scilit:
- Associations between reporting of cancer alarm symptoms and socioeconomic and demographic determinants: a population-based, cross-sectional studyBMC Public Health, 2012
- Incomplete inside-out growth pattern in invasive breast carcinoma: association with lymph vessel invasion and recurrence-free survivalVirchows Archiv A Pathological Anatomy and Histopathology, 2011
- Characteristics of Invasive Micropapillary Carcinoma of the Breast: In Comparison with Invasive Ductal CarcinomaJournal of Breast Cancer, 2010
- Mixed micropapillary–ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct componentsThe Journal of Pathology, 2009
- Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breastThe Journal of Pathology, 2008
- Breast Carcinoma With Micropapillary Features: Clinicopathologic Study and Long-Term Follow-Up of 100 CasesInternational Journal of Surgical Pathology, 2008
- Effect of Screening and Adjuvant Therapy on Mortality from Breast CancerThe New England Journal of Medicine, 2005
- Invasive Micropapillary Carcinoma of the BreastAmerican Journal of Clinical Pathology, 2004
- Invasive Micropapillary Carcinoma of the Breast : Clinicopathologic Study of 62 Cases of a Poorly Recognized Variant With Highly Aggressive BehaviorAmerican Journal of Clinical Pathology, 2004
- Clinicopathologic Analysis of Invasive Micropapillary Differentiation in Breast CarcinomaLaboratory Investigation, 2001